|
Treatment schedule
|
No. (%)
|
|---|
|
Chemotherapy
|
|
Neo + RT
|
77 (41.8)
|
|
Neo + CCRT
|
23 (12.5)
|
|
Neo + RT + Adj
|
17 (9.2)
|
|
CCRT
|
10 (5.4)
|
|
CCRT+Adj
|
4 (2.2)
|
|
Neo + CCRT+Adj
|
2 (1.1)
|
|
RT + Adj
|
5 (2.7)
|
|
IMRT alone
|
46 (25)
|
|
Cetuximab
|
9 (4.8)
|
|
Nimotuzumab
|
10 (5.4)
|
|
IMRT
|
|
IMRT dose (Gy)
|
|
Median (range)
|
66.7 (42–77)
|
|
Fractional dose(Gy)
|
|
1.8
|
1 (0.5)
|
|
2.0
|
125 (67.9)
|
|
2.1
|
44 (23.9)
|
|
2.2
|
6 (3.3)
|
|
2.3
|
7 (3.8)
|
|
IMRT treatment duration (days)
|
|
Median (range)
|
46 (29–64)
|
|
Brachytherapy
|
13 (7.1)
|
- Abbreviations: NPC, nasopharyngeal carcinoma; Neo, neoadjuvant chemotherapy; RT, radiotherapy; CCRT, concurrent chemoradiotherapy; Adj, adjuvant chemotherapy; IMRT, intensity-modulated radiotherapy
